Armin Bauer

Armin Bauer

Auto-generated profile, based on publicly available information

Armin Bauer

Sanofi R&D, Integrated Drug Discovery, Industriepark Höchst, Building G838, 65926 Frankfurt am Main, Germany

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2013 in Natural Product Reports
Verified
Journal Article
Closed access
PDF file
ABArmin Bauer
Armin Bauer
Mark BrönstrupMark Brönstrup
Mark Brönstrup
Covering: up to March 2013 In addition to their prominent role in basic biological and chemical research, natural products are a rich source of commercial products for the pharmaceutical and other industries. Industrial natural product chemistry is of fundamental importance for successful product development, as the vast majority (ca. 80%) of commercial drugs derived from natural products require synthetic efforts, either to enable economical access to bulk material, and/or to optimize drug properties through structural modifications. This review aims to illustrate issues on the pathway from lead to product, and how they have been successfully addressed by modern natural product chemistry. It is focused on natural products of current relevance that are, or are intended to be, used as pharmaceuticals.

11 August 2020 in Journal of Medical Internet Research
Verified
Journal Article
Open access
MGMaren Goetz
Maren Goetz
CSClaudia Schiele
Claudia Schiele
MMMitho Müller
Mitho Müller
LMLina M Matthies
Lina M Matthies
TDThomas M Deutsch
Thomas M Deutsch
SWStephanie Wallwiener
Stephanie Wallwiener
Background: Peripartum depression and anxiety disorders are highly prevalent and are correlated with adverse maternal and neonatal outcomes. Antenatal care in Germany does not yet include structured screening and effective low-threshold treatment options for women facing peripartum depression and anxiety disorders. Mindfulness-based interventions (MBIs) are increasingly becoming a focus of interest for the management of such patients. Studies have shown a decrease in pregnancy-related stress and anxiety in expectant mothers following mindfulness programs. Objective: The aim of this study was to explore the clinical effectiveness of a 1-week electronic course of mindfulness on prenatal depression and anxiety in hospitalized, high-risk pregnant women. We hypothesized that participating in a 1-week electronic MBI (eMBI) could alleviate symptoms of depression and anxiety during the hospital stay. Methods: A prospective pilot study with an explorative study design was conducted from January to May 2019 in a sample of 68 women hospitalized due to high-risk pregnancies. After enrolling into the study, the participants were given access to an eMBI app on how to deal with stress, anxiety, and symptoms of depression. Psychometric parameters were assessed via electronic questionnaires comprising the Edinburgh Postnatal Depression Scale (EPDS), State-Trait Anxiety Inventory (STAI-S), and abridged version of the Pregnancy-Related Anxiety Questionnaire (PRAQ-R). Results: We observed a high prevalence of peripartum depression and anxiety among hospitalized high-risk pregnant women: 39% (26/67) of the study participants in the first assessment and 41% (16/39) of the participants in the second assessment achieved EPDS scores above the cutoff value for minor/major depression. The number of participants with anxiety levels above the cutoff value (66% [45/68] of the participants in the first assessment and 67% [26/39] of the participants in the second assessment) was significantly more than that of the participants with anxiety levels below the cutoff value, as measured with the STAI-S. After completing the 1-week electronic course on mindfulness, the participants showed a significant reduction in the mean state anxiety levels (P<.03). Regarding pregnancy-related anxiety, participants who completed more than 50% of the 1-week course showed lower scores in PRAQ-R in the second assessment (P<.05). No significant changes in the EPDS scores were found after completing the intervention. Conclusions: Peripartum anxiety and depression represent a relevant health issue in hospitalized pregnant patients. Short-term eMBIs could have the potential to reduce anxiety levels and pregnancy-related anxiety. However, we observed that compliance to eMBI seems to be related to lower symptoms of pregnancy-related stress among high-risk patients. eMBIs represent accessible mental health resources at reduced costs and can be adapted for hospitalized patients during pregnancy.

15 March 2022 in ACS Catalysis
Verified
Journal Article
Closed access
KMKathiravan Murugesan
Kathiravan Murugesan
KDKarsten Donabauer
Karsten Donabauer
RNRok Narobe
Rok Narobe
VDVolker Derdau
Volker Derdau
ABArmin Bauer
Armin Bauer
Burkhard KoenigBurkhard Koenig
Burkhard Koenig


13 July 2018 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
GJGerrit Jürjens
Gerrit Jürjens
SSSören M. M. Schuler
Sören M. M. Schuler
MKMichael Kurz
Michael Kurz
SPSylvain Petit
Sylvain Petit
CCCédric Couturier
Cédric Couturier
ABArmin Bauer
Armin Bauer

2 February 2023 in ACS Catalysis
Verified
Journal Article
Closed access
KKKorkit Korvorapun
Korkit Korvorapun
YBYannick T. Boni
Yannick T. Boni
TMThomas C. Maier
Thomas C. Maier
ABArmin Bauer
Armin Bauer
TLThomas Licher
Thomas Licher
HDHuw M. L. Davies
Huw M. L. Davies